As of 2026-03-19, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 21.3x | 18.3x |
| Forward P/E multiples | 20.4x - 32.6x | 22.4x |
| Fair Price | (6,073.55) - (6,353.41) | (6,058.66) |
| Upside | -9301093.7% - -9729668.9% | -9278297.1% |
| Date | EV/EBITDA |